Top Tech Companies in NYC, NY (10,000+)
Ghostery is one of the most recognizable and popular brands in the privacy space, with a wildly successful browser extension and mobile browsers that are relied upon by millions of people around the world. We aim to provide a cleaner, faster, and safer browsing experience for our users by detecting and blocking tracking technologies on websites.
We help small businesses better compete with the big guys. Building financial infrastructure specifically for Small and Medium businesses
Barclays is a British universal bank. We are diversified by business, by different types of customers and clients, and by geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services...
We at iB Arts Pvt Ltd offer high-quality website design & development services, mobile app development, Digital marketing & Branding services for all types of businesses, and Industry Verticals. iB Arts Pvt. Ltd. is an ISO 9001:2015 certified IT services provider in India empowering global businesses for over 7+ years. Achieve your business goal with our extensive yet specialized spectrum of...
Edelman Heating, Cooling, Plumbing, Electric & Solar is a family-owned business that has provided high-quality HVAC, plumbing, electrical, and solar solutions to homes and businesses across Illinois and Wisconsin for over 20 years. Specializing in installation, repair, and maintenance, they employ NATE-certified technicians and are committed to 100% customer satisfaction, ensuring reliable home comfort services for their residential and commercial...
We are a global workplace strategy, design, and construction leader creating experiential spaces for a rapidly changing world. We believe our spaces should spark brilliance in people who use them. Together as One Team, we create environments that deepen connections, foster a sense of belonging and propel success. As we knock down the barriers between strategy, design, and construction, we...
WSP is a leading engineering professional services consulting firm which supports significant projects in both the built and natural environments. We provide engineering and design services to public and private sector clients in the transportation and infrastructure, property and buildings, earth and environment, power and energy, resources and industry sectors, as well as a strategic advisory offering. We have more than...
We bring people together to build the future of business. We are cloud technologists with deep expertise in platforms including Oracle NetSuite, Boomi, Celigo, Workato, and more.
Fy for the same price, every time. $199/month • $35/flight • 5 one way flights per month.
We understand that to brands, audiences are everything. OUTFRONT provides an integrated and target platform to connect brands to their target audiences, as they live their lives. We leverage the power of technology, location, and creativity to drive impact and engagement between brands and audiences. OUTFRONT delivers truth, trust, and transparency. Impact where it matters. We Get You America. OUTFRONT was...
OUTFRONT Media's Top Stability & Growth Strengths
Strong Market Position & Advantage: OUTFRONT is a top‑three OOH owner in North America and a clear leader in U.S. transit, anchored by its exclusive MTA concession and major‑market coverage. Programmatic urban networks and New York scale reinforce a durable competitive position.
Innovation-Driven Growth: Expansion of programmatic buying across thousands of digital transit screens and continued digitization are driving more data‑driven monetization. These initiatives align with industry growth in digital OOH and support yield improvement.
Profitability: Recent quarters show improved profitability and cash generation, with gains in Adjusted OIBDA and AFFO alongside a maintained dividend. Transit strength and digital mix have contributed to better margins and cash flow.
Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive medicine and maternal health, and in areas of gastroenterology and urology. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring was founded in 1950 and employs more than...
Ferring Pharmaceuticals's Top Stability & Growth Strengths
Strong Revenue Growth: 2025 revenues exceeded €2.5 billion, rising versus 2024 with notable momentum in the U.S. and key contributions from Menopur and Adstiladrin. Company disclosures and the annual report indicate continued year-over-year top-line expansion.
Innovation-Driven Growth: First-in-class approvals (Rebyota in microbiome therapeutics and Adstiladrin in bladder-cancer gene therapy) and WHO-recognized maternal-health innovation (heat-stable carbetocin) demonstrate differentiated science translating into commercial progress. FDA clearance of a second U.S. Adstiladrin site supports scaling these innovations.
Strong Market Position & Advantage: Leadership in ART/fertility and first-mover status in microbiome therapeutics and intravesical gene therapy provide competitive advantages in defined niches. This positioning underpins recent growth in core franchises.
Americaneagle.com is an industry leader in professional website design, strategy, development, and hosting. We're truly a one-stop shop offering a full range of solutions for anyone looking to succeed in their online endeavors. Americaneagle.com is a family owned, privately held company with a long history of profitability and stability.
PortPro is a privately-owned technology company providing an AI-powered transportation management system (TMS) and operational software specifically designed for drayage carriers and freight brokerages. Their platform, including drayOS and PortPro AI, helps these companies automate workflows from delivery order to payment, optimize driver utilization, and recover revenue by plugging operational inefficiencies.
AMETEK, Inc. is a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of approximately $5.5 billion. AMETEK has over 18,500 colleagues at more than 150 operating locations in 30 countries around the world. Our mission is to solve our customers' most complex challenges with differentiated technology solutions. The AMETEK Growth Model combines its four growth strategies of Operational...
AMETEK's Top Stability & Growth Strengths
Profitability: Profitability appears structurally strong, supported by operating margins above the mid‑20s and consistently strong free cash flow generation. Margin expansion and high conversion are also highlighted alongside record operating profit and EBITDA outcomes.
Strong Revenue Growth: Revenue shows a clear upward trend with multiple record quarters and year-over-year growth, alongside guidance calling for additional growth in the next year. Orders and backlog strength also support continued top-line momentum.
Innovation-Driven Growth: Innovation is reinforced through substantial R&D investment and a meaningful contribution from recently introduced products. Targeted acquisitions that add metrology and ultra-precision capabilities further extend the technology portfolio.
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we...
Regeneron's Top Stability & Growth Strengths
Product Line Growth: The company is growing on financials and products, with momentum attributed to EYLEA HD, Libtayo, and rising Dupixent collaboration revenue alongside shareholder-return actions (dividend and buybacks) reinforcing the trend in 2024–2025.
Future-Ready Strategy: The setup for 2025–2026 includes multiple identified catalysts, including the odronextamab FDA decision (target action date July 30, 2025), further EYLEA HD label/formulation updates, and the ongoing Dupixent COPD rollout as key determinants for sustaining or accelerating growth.
Innovation-Driven Growth: A science-driven platform approach (including VelocImmune, the Regeneron Genetics Center, and advanced proteomics/genomics) is positioned as enabling rapid therapeutic discovery across multiple therapeutic areas, supporting an ongoing pipeline-led growth thesis.
CDS is the leading provider of multi-vendor support (MVS) services for data centers worldwide. Its Raytrix MVS software platform offers a range of mission-critical data center hardware maintenance and support for high-end storage, server and network equipment. CDS offers post-warranty support services through OEMs and channel partners, servicing a diversified customer base throughout the Americas, EMEA, Asia Pacific, and Japan....
Make a living from your passion by selling memberships, online courses, and digital downloads to your audience
Appinventiv redefines mobile experiences- through transformation aided by technology. We are the leading global product development and digital transformation agency that’s empowering disruptive startups and fortune companies in bridging the gap between ideas and reality through new-age technology. We are a team of passionate 700+ mobile experts who dream, architect, design and develop with one relentless pursuit- to craft innovative solutions...
We believe experience matters. Founded in 1979, GMR is an innovative global sponsorship and experiential leader, connecting brands and their consumers through shared passions. We change how people think, feel and behave through the power of experience. Experiences founded on data, rooted in insight, grounded in strategy, designed meticulously and executed flawlessly. Our passionate global team creates, consults and activates...
Mallinckrodt Pharmaceuticals plc is a global specialty pharmaceutical company with over 150 years of experience. Historically a manufacturer of specialty pharmaceuticals, generic drugs, and imaging agents, the company transitioned in November 2025 to be known as Keenova Therapeutics. It now focuses on developing, manufacturing, and commercializing branded therapeutics designed to help patients with rare or unaddressed conditions live healthier and...
